Publications by authors named "Anais Zully Valencia"

The vaccine potential of Plasmodium falciparum liver stage antigen-3 (LSA3) was investigated in Aotus monkeys using two long synthetic peptides corresponding respectively to an N-terminal non-repeat peptide (NRP) and repeat 2 (R2) region of the LSA3, adjuvanted by ASO2. Both 100-222 (NRP) and 501-596 repeat peptides induced effector B- and T-cell responses in terms of antigen-driven antibodies and/or specific IFN-gamma secretion. Animals challenged with P.

View Article and Find Full Text PDF

Three long synthetic peptides corresponding to amino (N), repeat (R) and carboxyl (C) regions of the Plasmodium vivax circumsporozoite (CS) protein were synthesised and used to assess their potential as vaccine candidates. Antigenicity studies were carried out using human blood samples from residents of a malaria-endemic area of Colombia, and immunogenicity was tested in Aotus monkeys. The N and C peptides spanned the total native amino and carboxyl flanking regions, whereas the R peptide corresponded to a construct based on the first central nona-peptide repeated in tandem three times and colinearly linked to a universal T-cell epitope (ptt-30) derived from tetanus toxin.

View Article and Find Full Text PDF

Leishmania Viannia strains from 1,092 patients who acquired dermal leishmaniasis in endemic regions of Colombia were analyzed for expression of species and subgenus specific epitopes. Eight monoclonal antibodies prepared against membranes of the major species of the Viannia subgenus and previously shown to distinguish these species, recognized low molecular mass (< 45kD) membrane components. Thirteen widely but non-uniformly distributed serodemes were identified: one unique to L.

View Article and Find Full Text PDF

Specific CD8(-) T-lymphocyte (CTL) activity against Plasmodium pre-erythrocytic stages (P-ES) derived antigens is considered one of the most important mechanisms for malaria protection. Plasmodium vivax is the second most prevalent human malaria parasite species distributed worldwide. Although several CTL epitopes have been identified in Plasmodium falciparum P-ES derived antigens, none has been described for P.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Anais Zully Valencia"

  • - Anais Zully Valencia's recent research focuses on the vaccine potential and immune responses associated with various Plasmodium antigens, particularly those related to malaria, using synthetic peptides and animal models, like Aotus monkeys.
  • - The studies demonstrated that long synthetic peptides derived from Plasmodium falciparum liver-stage antigen-3 and Plasmodium vivax circumsporozoite protein can elicit significant B- and T-cell responses, indicating their potential as effective vaccine candidates for malaria.
  • - Additionally, her research includes investigating the heterogeneity and pathogenicity of Leishmania viannia strains in Colombia, contributing to the understanding of dermal leishmaniasis and its geographic distribution.*